Tenet Healthcare stock
THCNYSETenet Healthcare Corporation, HealthcareISIN US88033G4073
76Score 76 out of 100, Strong
Price and trend
88 / 100
Price history
+43% in one yearThe chart shows daily closes over 20 years, adjusted for stock splits and without dividends. Click into the chart to set a price alert at that price.
Above the 200-day line: the price is 28% above it.
Since August 2026 the 50-day line has been above the 200-day line; the trend has turned up.
Normal: the price is neither overheated nor sold off (RSI 62).
The price is 2.1% below its 52-week high. Largest decline in 20 years: 88% (May 2007 to March 2009).
Chart figures for advanced users
- SMA 50$267.40
- Average price of the last 50 trading days, shows the short-term trend.
- SMA 200$224.34
- Average price of the last 200 trading days, shows the long-term trend.
- RSI (14)62
- Relative strength over the last 14 days on a scale from 0 to 100. Above 70 the price counts as overheated, below 30 as sharply fallen.
- MACDabove the signal line
- Compares a fast and a slow price average. Above its signal line momentum is rising, below it momentum is fading.
- Support$161.37
- The lowest closing price of the last twelve months.
- Resistance$292.97
- The highest closing price of the last twelve months.
Snapshot
Computed from the data by fixed rules, no AI
- Tenet Healthcare Corporation belongs to the Medical (Care Facilities) industry (United States) and, with a market value of $22.83B, is number 3 of 57 companies in its industry on MEQIRI.
- In fiscal 2025 it reported revenue of $21.31B (up 3.1% year on year) and earnings of $1.41B (down 56%).
- For fiscal 2026, analysts expect on average revenue of $22.3B (up 4.7%) and adjusted earnings per share of $22.57 (up 34.5%).
Show more
- MEQIRI Score 76 out of 100 (Strong): rank 54 of 702 in Healthcare, median 53.
- The P/E is 8 (Medical (Care Facilities) median 19.6, own median of recent years 12.6).
- Our model puts fair value at $629.74, with the price 54% below it.
In plain words
The numbers on this page in plain words, written by an AI
Strengths
- Earnings per share growingUp 32.7% a year since 2020.Growth 66
- Modestly valuedP/E 8, Medical (Care Facilities) median 19.6, own median 12.6.Valuation 86
- Below fair valuePrice 54% below the fair value of $629.74.Valuation 86
Weaknesses
None of our weakness checks flags anything. Crash risk is measured separately.
Its standout strengths are momentum and technical analysis.
Daily figure as of 13 Nov 2026
How the score is calculatedScore overview
Fundamentals are strong, with strong cash generation.
Score history
The full history of up to 20 years comes with MEQIRI Pro.
See plansCrash risk medium
How well MEQIRI warnsIn the middle among stocks ranked 101 to 1,000.
From 2016 to 2025, 13 in 100 such stocks fell 30% or more within a year, against a group average of 15 in 100.
What drives the risk
- high price swings
What lowers it
- price near its 52-week high
- solid fundamentals
- stable momentum
Valuation
Valuation signal
Significantly undervaluedIn our model the price counts as cheap below $449.81 and expensive above $1,049.56 (uncertainty high, based on the price swings of the past year).
The two parts of the fair value come to $553.07 (cash-flow model) and $706.41 (industry comparison), and the gap between them shows how uncertain the estimate is. The price is below both.
Calculated with a cost of equity of 8.8%. At 9.8% the fair value would be $582.66, at 7.8% it would be $700.43.
Valuation metrics
Half from the cash-flow model, half from earnings times the industry P/E (19.6).
Calculate with your own assumptionsCompany performance
This shows several years of history with an automatic assessment.
Revenue
In the twelve months to 30 Sep 2026, revenue rose 9.3% on the twelve months before. Revenue has grown solidly since 2006, at about 5% per year.
Margins
- Gross margin
- Operating margin
- Net margin
In fiscal 2025: gross 82%, operating 16%, net 7%. Last 12 months: net 13%.
Debt & balance sheet
latest quarterDebt is elevated. Keep an eye on the interest burden and refinancing.
Earnings
- Next earnings
- 10 Feb 2027in 89 days
- Last reported
- 29 Oct 2026EPS reported $6.64 (expected $4.68)above expectations
Analyst estimates
Analysts have cut their 2027 earnings estimate by 3.5% since 15 Oct 2026. Falling estimates often precede bad news.
- Earnings per share
- $22.57+6.4%
- Revenue
- $22.3B+0.4%
- Earnings per share
- $20.35−3.5%
- Revenue
- $22.5B0.0%
MEQIRI has stored the estimates since 15 Oct 2026. Until 30 days are available, the card shows the change since that day. Mean estimate according to Financial Modeling Prep. No price target and no recommendation.
Company outlook raised
Share price after the results: +1.8%Tenet raised its 2026 outlook: adjusted EBITDA now $5.05 to $5.2 billion (up 4% at midpoint from prior guidance), revenue $22.05 to $22.45 billion, and free cash flow $1.925 to $2.155 billion, all above previous guidance.
“At this point in the year, we are raising our full year 2026 adjusted EBITDA guidance to a range of $5.05 to $5.2 billion which represents an increase of $195 million or 4% the midpoint of the range over our increased guidance after the second quarter.”The outlook is not part of the score and not a recommendation to buy or sell.
From the earnings call on 29 Oct 2026 (fiscal Q3 2026), read by AI.
Insiders
Open-market purchases and sales by executives, board members and major holders
No open-market purchases in the last 6 months. 11 insiders sold, $51.51M in total.
Sales say less than purchases: many insiders sell on a fixed plan, for taxes or to diversify.
- Kerrey J RobertSale
14 Sept 2026, Board
- Shares
- 12,010
- Price
- $263.72
- Value
- $3.17M
- Mark Richard JSale
10 Sept 2026, Board
- Shares
- 10,000
- Price
- $263.42
- Value
- $2.63M
- West NadjaSale
2 Sept 2026, Board
- Shares
- 1,152
- Price
- $258.80
- Value
- $298,138
Show 13 more
- Foo Lisa YSale
31 Aug 2026, EVP, Chief Operating Officer
- Shares
- 24,000
- Price
- $266.32
- Value
- $6.39M
- Sutaria SaumyaSale
25 Aug 2026, CEO
- Shares
- 50,000
- Price
- $274.02
- Value
- $13.7M
- Haney Cecil DSale
24 Aug 2026, Board
- Shares
- 1,300
- Price
- $278.03
- Value
- $361,439
- Sutaria SaumyaSale
24 Aug 2026, CEO
- Shares
- 50,000
- Price
- $278.71
- Value
- $13.94M
- Romo TammySale
7 Aug 2026, Board
- Shares
- 2,500
- Price
- $260.83
- Value
- $652,075
- Romo TammySale
6 Aug 2026, Board
- Shares
- 4,922
- Price
- $264.15
- Value
- $1.3M
- Blunt RoySale
5 Aug 2026, Board
- Shares
- 600
- Price
- $262.68
- Value
- $157,608
- Foo Lisa YSale
29 Jul 2026, EVP, Chief Operating Officer
- Shares
- 10,000
- Price
- $258.03
- Value
- $2.58M
- Lynch Christopher S.Sale
27 Jul 2026, Board
- Shares
- 3,837
- Price
- $243.44
- Value
- $934,079
- Arbour Paola MSale
27 Jul 2026, EVP, Chief Information Officer
- Shares
- 10,878
- Price
- $243.90
- Value
- $2.65M
- Bierman James LSale
27 Jul 2026, Board
- Shares
- 5,000
- Price
- $244.96
- Value
- $1.22M
- Kerrey J RobertSale
28 May 2026, Board
- Shares
- 5,638
- Price
- $174.52
- Value
- $983,920
- West NadjaSale
27 May 2026, Board
- Shares
- 3,000
- Price
- $177.35
- Value
- $532,050
Partial trades from one filing are shown in one row, with the average price.
Source: Form 4 filings with the US Securities and Exchange Commission. Grants, option exercises, gifts and tax withholdings are hidden. Not a recommendation to buy.
What happened at Tenet Healthcare
The key events of the last six months from our own data. A click takes you to the matching card.
Sector comparison
702 rated companies in Healthcare
- This company
- 76
- Sector median
- 53
Categories against the sector median
The median is the middle value: half of the companies in the sector lie above it, half below. Categories with too few comparable companies are left out.
Competitors in Medical (Care Facilities)
The next larger and next smaller companies by market value
- HCA HealthcareHCA $104.58B75
- Fresenius SE & Co. KGaAFRE.DE $33.26B56
- Encompass HealthEHC $13.82B75
- Rede D'Or São LuizRDOR3.SA $13.29B62
- Apollo Hospitals EnterpriseAPOLLOHOSP.NS $13.01B70
- Aier Eye Hospital Group300015.SZ $12.04B66
- Universal Health ServicesUHS $11.4B73
- Fresenius Medical Care AG & Co. KGaAFME.DE $11.38B57
ETFs that hold Tenet Healthcare
Held by 17 ETFs on Xetra. Shown per index: the ETF with the largest weight.
| ETF | Weight | Cost | Fund size |
|---|---|---|---|
| iShares Ageing Population UCITS ETF2B77 | 0.83% | 0.40% | €813.42M |
| State Street SPDR S&P 400 U.S. Mid Cap UCITS ETF (Acc)SPY4 | 0.69% | 0.30% | €5.36B |
| State Street SPDR MSCI USA Small Cap Value Weighted UCITS ETFZPRV | 0.52% | 0.30% | €964.08M |
Show 5 more
| First Trust US Large Cap Core AlphaDEX UCITS ETFFTGU | 0.39% | 0.75% | €142.73M |
| iShares MSCI USA Small Cap CTB Enhanced ESG UCITS ETFSXRG | 0.38% | 0.43% | €2.5B |
| Invesco Global Buyback Achievers UCITS ETFBBCK | 0.35% | 0.39% | €190.04M |
| State Street SPDR MSCI World Small Cap UCITS ETF (Acc)ZPRS | 0.24% | 0.45% | €1.54B |
| iShares MSCI World Small Cap CTB Enhanced ESG UCITS ETFCBUG | 0.23% | 0.10% | €395.74M |
Holdings as reported by the funds via FMP, excluding swap ETFs (their holdings are only collateral).
Data status and sources
- Score
- Daily value of 13 Nov 2026, recalculated nightly
- Price
- Closing price of 12 Nov 2026
- Latest annual report
- Fiscal year 2025, period end 31 Dec 2025
- Source
- Financial statements, ratios and prices from Financial Modeling Prep (FMP), based on the company's reports. MEQIRI calculates the score and fair value from them.
Mandatory disclosures for this rating
- ; time horizon around 12 months
- Rated Strong, published since 7 Nov 2026 (in the score history since 24 Jul 2026)
- Valuation signal Undervalued since 7 Nov 2026
- End-of-day prices, metrics cached for up to 24 hours
- Score and fair value are estimates from a disclosed model. They are not facts and not a price target.
- Produced by SSM Ventures UG (haftungsbeschränkt), responsible person Sven Brostmeyer, Managing Director, automatically according to the disclosed model.
- Not investment advice. Losses up to and including a total loss are possible. Personal circumstances are not considered.